Analysis: Alzheimer's Drug Treamtent Costs Patients $75,000 Per Year

The video discusses a costly Alzheimer's drug by Biogen, highlighting its high price, limited effectiveness, and significant side effects. Despite FDA approval, the drug's cost remains a barrier, with patients potentially paying up to $75,000 annually. The drug works by targeting brain plaques, but side effects like brain swelling are common. Insurance coverage is uncertain, with Medicare requiring further trials. Critics question the drug's value, given its modest impact on cognitive decline. Biogen is conducting further studies to address these concerns.

What new insight or understanding did you gain from this video?